scholarly journals Estrogen Receptors in Polycystic Ovary Syndrome

Cells ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 459
Author(s):  
Xue-Ling Xu ◽  
Shou-Long Deng ◽  
Zheng-Xing Lian ◽  
Kun Yu

Female infertility is mainly caused by ovulation disorders, which affect female reproduction and pregnancy worldwide, with polycystic ovary syndrome (PCOS) being the most prevalent of these. PCOS is a frequent endocrine disease that is associated with abnormal function of the female sex hormone estrogen and estrogen receptors (ERs). Estrogens mediate genomic effects through ERα and ERβ in target tissues. The G-protein-coupled estrogen receptor (GPER) has recently been described as mediating the non-genomic signaling of estrogen. Changes in estrogen receptor signaling pathways affect cellular activities, such as ovulation; cell cycle phase; and cell proliferation, migration, and invasion. Over the years, some selective estrogen receptor modulators (SERMs) have made substantial strides in clinical applications for subfertility with PCOS, such as tamoxifen and clomiphene, however the role of ER in PCOS still needs to be understood. This article focuses on the recent progress in PCOS caused by the abnormal expression of estrogen and ERs in the ovaries and uterus, and the clinical application of related targeted small-molecule drugs.

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Ali Aflatounian ◽  
Melissa Edwards ◽  
Robert Gilchrist ◽  
Michael Bertoldo ◽  
William Ledger ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Siyu Zhou ◽  
Shu Wen ◽  
Yongcheng Sheng ◽  
Meina Yang ◽  
Xiaoyang Shen ◽  
...  

PurposeControversial results existed in amounts of studies investigating the authentic association of estrogen receptor genes (ESR1 and ESR2) polymorphisms with the occurrence and progression of polycystic ovary syndrome (PCOS). The inconsistency might result from different loci, sample sizes, and ethnicities. To find the potential correlations between ESR1/ESR2 polymorphisms and PCOS risk, we conducted the first systematic review and meta-analysis to comprehensively summarize current studies in a large combined population.MethodsEligible studies were retrieved from PubMed, MEDLINE, EMBASE, Cochrane Library, CBM, CNKI, WANFANG, and VIP up to February 28, 2021. The quality of studies was assessed using the Newcastle–Ottawa Scale (NOS) scoring system. Odds ratios (ORs) and 95% confidence intervals (95%CIs) were calculated to synthesize data in five genetic models. Subgroup analyses were conducted by ethnicity. Heterogeneity and publication bias were also assessed. The protocol was registered in PROSPERO under the number CRD42021239200.ResultsA total of 8 studies involving 1,522 PCOS patients and 4,198 controls were included. No evidence demonstrated the association of ESR1 rs2234693 (OR=1.07 95%CI 0.98–1.18), ESR1 rs9340799 (OR=0.99 95%CI 0.69–1.43), or ESR2 rs4986938 (OR=1.06 95%CI 0.81–1.38) polymorphisms and PCOS risk in five genetic models. According to stratified subgroup analyses, ethnicity was considered the major source of heterogeneity. No publication bias was found in eligible studies.ConclusionThe present meta-analysis found no significant associations between the variants of ESR1 rs2234693, ESR1 rs9340799, ESR2 rs4936938, and individual PCOS susceptibility, even if ethnicity was taken into account.Systematic Review RegistrationThe protocol was registered in PROSPERO (available from https://www.crd.york.ac.uk/PROSPERO) with the ID number CRD42021239200.


2011 ◽  
Vol 23 (1) ◽  
pp. 256 ◽  
Author(s):  
A. E. Newell-Fugate ◽  
J. N. Taibl ◽  
S. G. Clark ◽  
M. Alloosh ◽  
M. Sturek ◽  
...  

The objective of this study was to validate the obese Ossabaw pig as a model of the obese polycystic ovary syndrome (PCOS) phenotype. Four sows were fed a high fat–high fructose diet to induce metabolic syndrome (MetS), and 5 sows were fed a control diet (Lean). Sows had twice-weekly blood collection and ovarian ultrasound; serum was assessed weekly for androstenedione (A) and twice weekly for progesterone (P). The follicular phase of the oestrous cycle was determined by absence of a corpus luteum on ultrasound and a nadir in P below 2.5 ng mL–1. After baseline measurement collection, sows were down-regulated with a GnRH agonist and superovulated with subcutaneous FSH/LH injections administered every 8 h until large follicles (5–12.5 mm) were visible on the ultrasound (3–7 days), at which point hCG was administered. Oestrous cycle data were divided into follicular (F), early luteal (EL), mid-luteal (ML), late luteal (LL), and transition (T) phases. Superovulation data were subdivided by percentage of stimulation completion and number of days post-hCG. Non-normal data were transformed before analysis with PROC MIXED for repeated-measures in SAS. The MetS sows had a longer average oestrous cycle length than did Lean sows (MetS, 32.2 ± 1.3 days; Lean, 25.2 ± 1.0 days; P < 0.05). In each cycle phase, with the exception of T, MetS A (F: 1.95 ± 0.01 ng mL–1, EL: 1.31 ± 0.07 ng mL–1, ML: 1.14 ± 0.04 ng mL–1, LL: 1.34 ± 0.04 ng mL–1) was higher (P < 0.05) than Lean A (F: 1.11 ± 0.09 ng mL–1, EL: 0.98 ± 0.07 ng mL–1, ML: 0.98 ± 0.04 ng mL–1, LL: 1.04 ± 0.04 ng mL–1). Within the MetS sows, A was significantly higher in F compared with the entire luteal (L) phase (1.25 ± 0.05 ng mL–1; P < 0.05). The MetS sows had similar numbers of large follicles in the F (3.0 ± 1.1 avg pig–1) and L (3.6 ± 1.1 avg pig–1) phases, whereas Lean sows had fewer large follicles during L (0.7 ± 1.1 avg pig–1) compared with F (3.0 ± 1.1 avg pig–1) phase (P < 0.05). The MetS sows had more large follicles than did Lean sows during the EL (MetS, 7.0 ± 1.1, Lean, 0.0 ± 0.0; P < 0.05) and T phases (MetS, 4.0 ± 1.1; Lean, 1.0 ± 1.1; P < 0.05). Lean sows did not form any cystic structures (CS; >12.5 mm). The MetS sows had significantly more CS than did Lean sows during the EL and ML phases (2.0 ± 0.5 avg pig–1; P < 0.05). In response to superovulation, MetS sows had higher A than did Lean sows at completion of stimulation (MetS, 8.45 ± 1.75 ng mL–1; Lean, 2.79 ± 1.36 ng mL–1; P < 0.05) and tended to have higher A than did Lean sows one day post-hCG administration (MetS, 6.00 ± 1.75 ng mL–1; Lean, 2.53 ± 1.36 ng mL–1; P = 0.09). Although not significantly different, MetS sows produced higher numbers of large follicles (range: 9.0–58.6 avg pig–1) than did Lean sows (range: 6.3–33.3 avg pig–1). In conclusion, MetS sows have long oestrous cycles, are hyperandrogenemic, have increased numbers of large follicles in the luteal phase, form cystic structures, and may recruit abnormally high numbers of large follicles in response to superovulation. The obese Ossabaw sow is an excellent animal model in which to study PCOS because women with this disease similarly have oligomenorrhea, hyperandrogenism and ovarian cysts, and recruit high numbers of large follicles at superovulation.


2002 ◽  
Vol 87 (12) ◽  
pp. 5532-5538 ◽  
Author(s):  
Artur J. Jakimiuk ◽  
Stacy R. Weitsman ◽  
Hui-Wen Yen ◽  
Michal Bogusiewicz ◽  
Denis A. Magoffin

2010 ◽  
Vol 93 (6) ◽  
pp. 1942-1947 ◽  
Author(s):  
Jin Ju Kim ◽  
Young Min Choi ◽  
Seon Ha Choung ◽  
Sang Ho Yoon ◽  
Gyoung Hoon Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document